Abstract:
A natural urease inhibitor is provided to inhibit activity of urease of Helicobacter pylori without side effects, thereby inhibiting colony formation of Helicobacter pylori. A method for inhibiting ammonia formation is also provided to inhibit ammonia formation from the excretions of domestic animals by using the urease inhibitor. A natural inhibitor of Helicobacter pylori urease contains 0.1-5.0 mM of glutathione. A health food for inhibiting Helicobacter pylori urease contains glutathione. The ammonia formation from the excretions of domestic animals is inhibited by spraying the urease inhibitor containing glutathione to the domestic animal excretions.
Abstract:
본 발명은 허수테논(hirsutenone)을 포함하는 건강 증진용 식품에 관한 것으로, 본 발명에 따른 조성물은 매트릭스 메탈로프로티나아제 (Matrix metalloproteinase : MMP)의 활성을 저해함으로써 간암의 진행과 전이를 억제하는데 유용하게 사용될 수 있으며, 이러한 목적을 갖는 약제, 가공 식품, 기능성 식품, 음료 및 주류의 제조에도 이용될 수 있다.
Abstract:
본 발명은 유파틸린을 유효성분으로 함유함을 특징으로 하는 갭 결합을 통한 세포 간 정보전달 장애로 인한 당뇨, 대뇌허혈, 차코-마리-투드 1형을 포함한 신경계 질환, 정자형성 이상질환, 심혈관계 고혈압을 포함하는 혈관계 질환, 신장 질환, 간질 또는 근질환을 예방하기 위한 조성물에 관한 것으로, 손상된 "갭결합을 통한 세포간 정보전달"을 회복시키고, 항상성을 유지시킴으로써, 갭 결합과 관련된 질환을 예방 및 치료하는 효과가 있다. 유파틸린, 갭 결합, 질환
Abstract:
PURPOSE: Provided is a composition for preventing and treating disease associated with inhibition of gap junctional internal cellular communication and unbalance of Homeostasis, containing hirsutenone, which composition contains Abies nephrolepis leaf extract and effectively recovers the inhibition of gap junctional internal cellular communication and the unbalance of Homeostasis. It is therefore, used for manufacture of medicaments, processed foods, functional foods, beverages and drinks. CONSTITUTION: A composition for preventing and treating disease associated with inhibition of gap junctional internal cellular communication and unbalance of Homeostasis is characterized by containing, as active ingredient, an effective amount of hirsutenone represented by the formula(1) and pharmaceutically acceptable carriers.
Abstract:
A composition comprising eupatilin is provided to inhibit activity, saturation, and mobility of matrix metalloproteinase(MMP), thereby being usefully used for inhibiting progress and metastasis of breast cancer. The composition for inhibiting progress or metastasis of breast cancer comprises eupatilin represented by the formula(1) and is used for preparing medicines, processed foods, functional foods, drinks and liquors having the breast cancer progress and metastasis inhibition function.
Abstract:
A composition comprising eupatilin is provided to recover intercellular communication through gap junction damaged by phenazine methosulfate(PMS) and maintain homeostasis thereof, thereby being able to effectively treat and prevent gap junction related diseases. The preventive composition for diseases mediated with gap junctional intercellular communication damage is characterized in that it comprises eupatilin as an effective ingredient. The composition is used in a health food, a food additive, and a feed.
Abstract:
본 발명은 허수테논(hirsutenone)을 포함하는, 갭 결합을 통한 세포간 정보전달의 억제 및 항상성의 불균형과 관련된 질환의 예방 또는 치료용 조성물에 관한 것으로서, 본 발명에 따른 조성물은 갭 결합을 통한 세포간 정보전달의 억제 및 항상성 불균형을 효과적으로 회복시키므로, 이와 관련된 질환을 예방하고 치료하는데 유용하게 사용될 수 있으며, 이러한 목적을 갖는 기능성 식품 또는 음료의 제조에도 이용될 수 있다.